Largest health care companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
UnitedHealth Group leads the 170 health care companies ranked by total liabilities, at SAR 779.8B, ahead of CVS Health (SAR 668.3B) and AbbVie (SAR 514.6B). Figures as of 19 Nov 2026, 12:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupSAR 779.8B
- Median
- SAR 11.4B
- Combined market value
- SAR 34.12T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IDEXX LaboratoriesIDXX · Health Care | SAR 6.5B | SAR 206.4B | SAR 2,619.96 | 1.19% up | 1% up | ||
| 102 | InsuletPODD · Health Care | SAR 6.3B | SAR 36.4B | SAR 525.06 | 3.69% down | 55% down | ||
| 103 | Ascendis PharmaASND · Health Care | SAR 6.1B | SAR 66.5B | SAR 1,014.01 | 0.32% down | 29% up | ||
| 104 | Hims & Hers HealthHIMS · Health Care | SAR 6.1B | SAR 15B | SAR 63.95 | 2.85% down | 49% down | ||
| 105 | HaemoneticsHAE · Health Care | SAR 6B | SAR 21B | SAR 460.85 | 1.60% up | 64% up | ||
| 106 | InsmedINSM · Health Care | SAR 5.7B | SAR 98.6B | SAR 449.37 | 1.69% down | 40% down | ||
| 107 | Medpace HoldingsMEDP · Health Care | SAR 5.7B | SAR 67.9B | SAR 2,426.41 | 0.95% down | 10% up | ||
| 108 | BioMarin PharmaceuticalBMRN · Health Care | SAR 5.7B | SAR 44.6B | SAR 230.42 | 4.99% up | 17% up | ||
| 109 | LivaNovaLIVN · Health Care | SAR 5.3B | SAR 19.5B | SAR 354.62 | 2.85% up | 77% up | ||
| 110 | Neurocrine BiosciencesNBIX · Health Care | SAR 5.2B | SAR 61.8B | SAR 610.89 | 1.84% down | 17% up | ||
| 111 | argenxARGX · Health Care | SAR 5.1B | SAR 222B | SAR 3,530.63 | 0.66% down | 2% up | ||
| 112 | HealthEquityHQY · Health Care | SAR 4.8B | SAR 30.2B | SAR 365.01 | 4.45% down | 3% down | ||
| 113 | MSA SafetyMSA · Health Care | SAR 4.5B | SAR 25.6B | SAR 665.61 | 2.67% up | 16% up | ||
| 114 | Lantheus HoldingsLNTH · Health Care | SAR 4.3B | SAR 25B | SAR 382.60 | 0.20% up | 90% up | ||
| 115 | Merit Medical SystemsMMSI · Health Care | SAR 4.1B | SAR 19.3B | SAR 322.32 | 1.70% up | 1% up | ||
| 116 | West Pharmaceutical ServicesWST · Health Care | SAR 4.1B | SAR 105.6B | SAR 1,515.48 | 2.44% down | 57% up | ||
| 117 | MiniMed GroupMMED · Health Care | SAR 3.8B | SAR 17.9B | SAR 63.73 | 4.44% down | 8% down | ||
| 118 | ImmunityBioIBRX · Health Care | SAR 3.8B | SAR 26.7B | SAR 25.13 | 7.03% up | 232% up | ||
| 119 | Arrowhead PharmaceuticalsARWR · Health Care | SAR 3.3B | SAR 22.9B | SAR 161.71 | 0.28% up | 13% up | ||
| 120 | RepligenRGEN · Health Care | SAR 3.2B | SAR 41.4B | SAR 647.69 | 6.47% up | 12% up | ||
| 121 | United TherapeuticsUTHR · Health Care | SAR 2.9B | SAR 92.2B | SAR 2,165.60 | 1.16% down | 22% up | ||
| 122 | Legend BiotechLEGN · Health Care | SAR 2.7B | SAR 11.8B | SAR 60.95 | 0.87% up | 41% down | ||
| 123 | Globus MedicalGMED · Health Care | SAR 2.7B | SAR 35B | SAR 264.56 | 0.77% up | 14% down | ||
| 124 | Revolution MedicinesRVMD · Health Care | SAR 2.7B | SAR 129.7B | SAR 599.48 | 1.76% down | 129% up | ||
| 125 | NateraNTRA · Health Care | SAR 2.6B | SAR 157.5B | SAR 1,085.91 | 0.71% up | 28% up | ||
| 126 | ExelixisEXEL · Health Care | SAR 2.6B | SAR 62.5B | SAR 256.16 | 0.31% down | 63% up | ||
| 127 | LifeStance Health GroupLFST · Health Care | SAR 2.6B | SAR 19.6B | SAR 51.65 | 2.82% down | 123% up | ||
| 128 | AlkermesALKS · Health Care | SAR 2.5B | SAR 29.5B | SAR 175.73 | 3.08% up | 66% up | ||
| 129 | Madrigal PharmaceuticalsMDGL · Health Care | SAR 2.5B | SAR 34.7B | SAR 1,493.20 | 5.67% down | 27% down | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | SAR 2.3B | SAR 26.4B | SAR 502.63 | 1.43% down | 6% down | ||
| 131 | ChemedCHE · Health Care | SAR 2.1B | SAR 26.6B | SAR 2,050.75 | 0.01% down | 27% up | ||
| 132 | Caris Life SciencesCAI · Health Care | SAR 2.1B | SAR 21B | SAR 73.14 | 2.21% down | 19% down | ||
| 133 | Ligand PharmaceuticalsLGND · Health Care | SAR 2B | SAR 22.4B | SAR 1,120.46 | 1.67% up | 50% up | ||
| 134 | Mirum PharmaceuticalsMIRM · Health Care | SAR 2B | SAR 22.6B | SAR 346.93 | 0.59% up | 34% up | ||
| 135 | Travere TherapeuticsTVTX · Health Care | SAR 1.8B | SAR 18.1B | SAR 188.45 | 1.68% down | 45% up | ||
| 136 | Bio-TechneTECH · Health Care | SAR 1.8B | SAR 42.9B | SAR 272.89 | 0.17% up | 24% up | ||
| 137 | Roivant SciencesROIV · Health Care | SAR 1.6B | SAR 105.3B | SAR 145.28 | 0.05% up | 91% up | ||
| 138 | TG TherapeuticsTGTX · Health Care | SAR 1.6B | SAR 37.5B | SAR 248.02 | 5.44% up | 117% up | ||
| 139 | PenumbraPEN · Health Care | SAR 1.5B | SAR 47.4B | SAR 1,202.57 | 0.47% up | 15% up | ||
| 140 | GRAILGRAL · Health Care | SAR 1.3B | SAR 17.2B | SAR 382.98 | 3.57% down | 19% up | ||
| 141 | CRISPR TherapeuticsCRSP · Health Care | SAR 1.3B | SAR 14.6B | SAR 150.75 | 0.10% up | 18% down | ||
| 142 | VaxcytePCVX · Health Care | SAR 1.2B | SAR 34.7B | SAR 219.51 | 1.48% down | 23% up | ||
| 143 | Cogent BiosciencesCOGT · Health Care | SAR 1.1B | SAR 18.2B | SAR 104.32 | 0.14% down | 20% down | ||
| 144 | Adaptive BiotechnologiesADPT · Health Care | SAR 1.1B | SAR 17.3B | SAR 106.75 | 0.11% down | 74% up | ||
| 145 | 10x GenomicsTXG · Health Care | SAR 919.1M | SAR 28.2B | SAR 214.07 | 1.37% up | 247% up | ||
| 146 | GlaukosGKOS · Health Care | SAR 890.2M | SAR 51.8B | SAR 874.28 | 4.18% down | 145% up | ||
| 147 | Rhythm PharmaceuticalsRYTM · Health Care | SAR 788.3M | SAR 31B | SAR 446.52 | 2.08% up | 18% up | ||
| 148 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 735.3M | SAR 28B | SAR 356.53 | 0.06% down | 129% up | ||
| 149 | Kodiak SciencesKOD · Health Care | SAR 728.3M | SAR 24B | SAR 366.89 | 1.04% up | 399% up | ||
| 150 | Corcept TherapeuticsCORT · Health Care | SAR 708.4M | SAR 27.8B | SAR 254.28 | 3.25% down | 10% down | ||
| 151 | Twist BioscienceTWST · Health Care | SAR 633.6M | SAR 29.8B | SAR 436.43 | 3.88% up | 346% up | ||
| 152 | Kymera TherapeuticsKYMR · Health Care | SAR 612M | SAR 38.8B | SAR 454.36 | 0.32% down | 87% up | ||
| 153 | Scholar Rock HoldingSRRK · Health Care | SAR 595.6M | SAR 22B | SAR 180.05 | 6.48% up | 26% up | ||
| 154 | BillionToOneBLLN · Health Care | SAR 572.2M | SAR 16.4B | SAR 343.37 | 6.11% down | 4% down | ||
| 155 | ABIVAXABVX · Health Care | SAR 537.4M | SAR 27.5B | SAR 314.45 | 2.11% up | 32% down | ||
| 156 | Krystal BiotechKRYS · Health Care | SAR 428.5M | SAR 35.1B | SAR 1,182.84 | 5.62% up | 54% up | ||
| 157 | Definium TherapeuticsDFTX · Health Care | SAR 404.3M | SAR 15B | SAR 109.23 | 0.88% down | 168% up | ||
| 158 | ImmunovantIMVT · Health Care | SAR 391.7M | SAR 25.7B | SAR 124.42 | 0.12% down | 46% up | ||
| 159 | Summit TherapeuticsSMMT · Health Care | SAR 346.3M | SAR 31.5B | SAR 39.39 | 1.59% down | 36% down | ||
| 160 | ErascaERAS · Health Care | SAR 266.3M | SAR 18.1B | SAR 51.61 | 0.94% down | 395% up | ||
| 161 | Spyre TherapeuticsSYRE · Health Care | SAR 234.6M | SAR 36.1B | SAR 380.58 | 8.15% up | 332% up | ||
| 162 | Praxis Precision MedicinesPRAX · Health Care | SAR 224.2M | SAR 32B | SAR 1,144.77 | 0.04% up | 86% up | ||
| 163 | HeartflowHTFL · Health Care | SAR 220.6M | SAR 15.1B | SAR 172.13 | 2.51% down | 66% up | ||
| 164 | Protagonist TherapeuticsPTGX · Health Care | SAR 200.6M | SAR 31.1B | SAR 476.98 | 2.00% up | 51% up | ||
| 165 | CG OncologyCGON · Health Care | SAR 146.3M | SAR 26.8B | SAR 300.08 | 1.34% up | 97% up | ||
| 166 | Dianthus TherapeuticsDNTH · Health Care | SAR 140.7M | SAR 17.7B | SAR 315.01 | 3.45% down | 108% up | ||
| 167 | Edgewise TherapeuticsEWTX · Health Care | SAR 113.8M | SAR 17B | SAR 155.18 | 1.59% down | 86% up | ||
| 168 | Oruka TherapeuticsORKA · Health Care | SAR 62.6M | SAR 24.4B | SAR 359.12 | 0.60% down | 255% up | ||
| 169 | Belite BioBLTE · Health Care | SAR 37.8M | SAR 23.8B | SAR 586.02 | 0.94% down | 43% up | ||
| 170 | VeradermicsMANE · Health Care | SAR 34.3M | SAR 19.8B | SAR 468.35 | 0.62% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which health care companies rank first by total liabilities?
UnitedHealth Group (SAR 779.8B), CVS Health (SAR 668.3B) and AbbVie (SAR 514.6B) are the top three of the 170 health care companies ranked by total liabilities as of 19 Nov 2026, 12:23 UTC.
How many health care companies are in this ranking?
170 are ranked by total liabilities.
What are these health care companies worth together?
The 170 health care companies ranked by total liabilities have a combined market value of SAR 34.12T as of 19 Nov 2026, 12:23 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.